HomeCompareCAKFY vs EQR

CAKFY vs EQR: Dividend Comparison 2026

CAKFY yields 4.15% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EQR wins by $22.4K in total portfolio value
10 years
CAKFY
CAKFY
● Live price
4.15%
Share price
$4.10
Annual div
$0.17
5Y div CAGR
-2.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$408.34
Full CAKFY calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — CAKFY vs EQR

📍 EQR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCAKFYEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CAKFY + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CAKFY pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CAKFY
Annual income on $10K today (after 15% tax)
$352.44/yr
After 10yr DRIP, annual income (after tax)
$347.09/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, EQR beats the other by $4,307.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CAKFY + EQR for your $10,000?

CAKFY: 50%EQR: 50%
100% EQR50/50100% CAKFY
Portfolio after 10yr
$36.6K
Annual income
$2,941.97/yr
Blended yield
8.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CAKFY
No analyst data
Altman Z
4.1
Piotroski
6/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CAKFY buys
0
EQR buys
0
No recent congressional trades found for CAKFY or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCAKFYEQR
Forward yield4.15%5.87%
Annual dividend / share$0.17$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-2.5%15.8%
Portfolio after 10y$25.4K$47.8K
Annual income after 10y$408.34$5,475.61
Total dividends collected$4.1K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CAKFY vs EQR ($10,000, DRIP)

YearCAKFY PortfolioCAKFY Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$11,104$404.27$11,380$679.82$276.00EQR
2$12,291$409.05$13,014$837.25$723.00EQR
3$13,564$412.56$14,961$1,036.20$1.4KEQR
4$14,928$414.86$17,297$1,289.22$2.4KEQR
5$16,389$416.05$20,121$1,613.15$3.7KEQR
6$17,952$416.22$23,561$2,030.84$5.6KEQR
7$19,624$415.45$27,783$2,573.54$8.2KEQR
8$21,412$413.82$33,013$3,284.39$11.6KEQR
9$23,322$411.43$39,547$4,223.51$16.2KEQR
10$25,363$408.34$47,791$5,475.61$22.4KEQR

CAKFY vs EQR: Complete Analysis 2026

CAKFYStock

McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution division engages in the wholesale of pharmaceutical and other health care products. This division serves its customers through 90 wholesale branches that supply pharmaceutical products to approximately 40,000 pharmacies and hospitals, as well as operates 70 distribution centers in Europe. The Retail Pharmacy division operates approximately 2,000 owned pharmacies and approximately 8,000 members in its brand partnership program. This division also provides outpatient drug, e-commerce, and home care services primarily in Belgium, Ireland, Italy, and the United Kingdom under the Lloyds Pharmacy brand. In addition, this division provides traditional prescription drugs, over-the-counter products, and medical services. It also provides other services for pharmacists, such as the organization and management of pharmacy cooperation programs in the Great Britain, France, Portugal, and Belgium. The company was formerly known as Celesio AG and changed its name to McKesson Europe AG in September 2017. The company was founded in 1835 and is headquartered in Stuttgart, Germany. McKesson Europe AG is a subsidiary of McKesson Corporation.

Full CAKFY Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this CAKFY vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CAKFY vs SCHDCAKFY vs JEPICAKFY vs OCAKFY vs KOCAKFY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.